Click for next page ( 112


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 111
Appendix C Thimerosal Content in Licensed Vaccines (Adapted from FDA, 2001, AAP, 1999)

OCR for page 111

OCR for page 111
Ad ~ - A) v: a: o ~ - N As i_ o o - V o C) - ~: o V, S: _ C) V - Em ~ 1~ e:^ ~ ~= ~= ~~)~ 555 E e o-5 = it= _ s ,O ~ = - o, a Cal 3 _ '_ U. 3 ~0 - ,, 1~, ~ =, 3 ~ O ~ ~ ~ O ~ ~ O _ _ o Z Z to V O O O O O 0 00 Ct O C) ~ 'C) X ~ Ct 3 ~ ~ ~ .~ U., ~ X ~ ~ c: 3 z E .= X ~ =, ~ o o rs U) m .= ~ ~ ~ ~ ~ ~ D : - ~ ~ ~ i'8 ~ ~o O O O ~ <1 _ Z Z O 00 ~ ~0 7 O O O O O O. O. . O O 3 ~ ~ ~ << ~ U. , U. _ ~ '_ ~ C,) ~ C) <: 3 <~ .. ~ ~ e ~ :~ ~ e, :: 0 Q41 =~3 2' ~ 3 ~ ~ ~ ~g _ C C~ 4, ._ o qe, oo o Z ~ C =~!

OCR for page 111
~ o v ~ o o o o v - - x ~ Ct Cat ? - 2 X 2 C C~ C E A, ~ m ~ ~ := a_ 0 0 z <,^ no ;. Ceder O O ~ ~ US ~ O - ~S o E s ._ o V z Cal s C~ o s _ s V a a ;^ L4 V of 0 0 0 0 0 0 of 0 0 of 0 0 ~O U. U3 == ~ ~ X _ X ~ ~ e ~ :E S :: o .~ ._ - 8 s - v I: C) C, ~: L. - ~ v s o - - o z ~a - ~z o. o Q) - .- ~3 3 CC s~ b0 o O Z ~ o Pa = ~: * ~ ~ 3 ~ U. E o Ct o ~D C, - c) Ct s C) * ~ -6] 18 ~ ~ U., 6 o o U. w ;^ c c o >` o - ~C C~ . C, c ec :> U. c :C oo V~ - ~ o o o ,, ~o . _ {C - _ _ o, o ~ .= .= o t ~ Q ~ W . o oo ~,. ~ o 3 ~ ^e .U' ~W7 ~ , o ~ ~ C) = ~ ~ ~ 6 . C ~ ~ 4,, _ 0 ' ~ c =0 O ~ - - ~ ~ _ C E ~ ~ ,..= at < 2 ~ Z ~ ~ . ~ ~ Z

OCR for page 111
115 IMMUNIZE TION SAFETYREVIEW TABLE C-2 Currently Licensed Vaccines That Are Recommended for Some Children Current Thimerosal Content (June 2001) Vaccine Brand Name Manufacturer % Thim Cone Hg ~g/05mL DT All Products Lederle 0.01 25 (Dipithe asthma toxoid) TT All Products Lederle 0.01 25 (Tedious Toxoid) Hepatitis A Havrix A SmithKline Beecham 0 0 Vaqta Merck 0 0 Influenza All Aventis Pasteur, 0.01 25 Medeva, and Led erl e- Wyeth NOTE: The formulation of vaccines listed in C-2 and C-3 have not changed since August/September 1999. TABLE C-3 Over Licensed Vaccines in the United States Current Thimerosal Content (June 2001) Vaccine Brand Name Manufacturer % Thim Cone Hg ~g/0~5mL Anthrax Anthrax BioPort Corporation 0 0 Vaccine BCG N/A N/A . . Hepatitis A- Twinrix Glaxo-SmithKline 0 0 Hepatitis B Hepatitis B Engerix B Glaxo-SmithKline 0.00S 12.5 (~/tfonn~Jotion) Recombivax Merck 0.005 12.5 HE (it fo~lat~on) Lyme LYMErix Glaxo-SmithKline 0 0 Meltings Menomune A, Aventis Pasteur 0.01 25 coccal6 C, AC and A/C/YM[-1 35 Rabies MOVAX Aventis Pasteur 0 0 Rabavert Chiron 0 0 Rabies Vaccine Bioport Corporation N/A N/A Adsorbed7 Typhoid Typhim Vi Aventis Pasteur 0 0 Fever Typhoid Ty21a V~votefBema 0 0 Typhoid Vac- Wyeth-Ayerst 0 0 cine Yellow Y-F-Vax Aventis Pasteur 0 0 Fever 6 Menomunc AJC/YIW-135, a thimerosal-containing vaccine, is not indicated for infants and children younger teal? 2 yews of age except as short-tenn protection of infants 3 months and older against Group ~ (Physician 's Desk Reference, 2001). ' This vaccine is no longa available but did contain 0.01% thimerosal ( 25 fig Hg/O.SmL). N/A means that the product is no longer currently produced or distributed in We United States.

OCR for page 111